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Abstract 
Increased expression of progesterone receptor (PR) has been reported in gastric cancer (GC). 
We have previously identified a functional T889C point mutation in DNA polymerase beta 
(POLB), a DNA repair gene in GC. To provide a detailed analysis of molecular changes associated 
with the mutation, human cDNA microarrays focusing on 18 signal transduction pathways were 
used to analyze differential gene expression profiles between GC tissues with T889C mutant in 
POLB gene and those with wild type. Among the differentially expressed genes, notably, PR was 
one of the significantly up-regulated genes in T889C mutant POLB tissues, which were 
subsequently confirmed in POLB gene transfected AGS cell line. Interestingly, patients with T889C 
mutation and PR positivity were associated with higher incidence of intraperitoneal metastasis 
(IM). In vitro studies indicate that PR expression was upregulated in AGS cell line when transfected 
with T889C mutant expression vector. Cotransfection of T889C mutant allele and PR gene 
induced cell migration in the cell line. These data demonstrated that T889C mutation-associated 
PR overexpression results in increased IM. Therefore, T889C mutation-associated PR 
overexpression may serve as a biomarker for an adverse prognosis for human GC. 
Key words: Gastric cancer, DNA polymerase beta, progesterone receptor, metastasis. 
Introduction 
Gastric cancer (GC) is the fourth most commonly 
diagnosed malignancy and the second leading cause 
of cancer-related mortality worldwide [1]. Influences 
of sex-hormones on gastric cancer development have 
been studied [2]. Progesterone is a critical regulator of 
normal female reproductive function, with diverse 
tissue-specific effects in humans. Progestogen has 
been classified by the International Agency for 
Research on Cancer (IARC) as possibly carcinogenic 
to humans and plays a role in cancer development 
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and progression [3]. The effects of progesterone 
mediated by its nuclear receptor, progesterone 
receptors (PR), have been reported in adenocarcinoma 
of the stomach [4]. Further, primarily altering PR 
expression levels rather than impacting PR 
transcriptional activity has been reported to be 
involved in human cancer progression [5]. However, 
the roles of PR expression in GC are poorly defined.  
Defective DNA repair can result in genomic 
instability and consequently induce oncogenic 
alterations. Base excision repair (BER) is a key 
pathway for maintaining genomic stability. A key 
enzyme in the BER pathway is DNA polymerase beta 
(POLB) [6-9]. POLB gene mutation and 
overexpression have been reported in various cancers 
including GC [10-13]. However, the detailed 
mechanism remains unclear. 
In our previous studies, we identified a unique 
T889C missense mutation in POLB gene in human 
primary GCs [14]. Here, we investigate changes in 
gene expression associated with the T889C mutation 
in POLB gene using cDNA microarray technology. 
Interestingly, among the differentially expressed 
genes, notably, PR was one of the significantly 
up-regulated genes in T889C mutant POLB tissues. 
Patients with T889C mutation and PR positivity were 
associated with higher incidence of intraperitoneal 
metastasis (IM). Further functional relationship 
between PR expression and T889C mutation in GC 
cell line was investigated.  
Materials and Methods 
Cell lines and tissue samples 
Human GC cell line AGS was obtained from the 
American Type Culture Collection (ATCC) and 
cultured in Dulbecco's modified Eagle's medium 
(DMEM) (Gibco) containing 10% fetal bovine serum 
(Gibco) and 10 μg/ml vancomycin. Primary GC 
specimens and their matched normal adjacent tissues 
were collected at the time of surgery. None of the 
patients had received any chemotherapy or 
radiotherapy before surgical resection. Tissue samples 
were snap-frozen in liquid nitrogen until further use. 
Clinical and histological features were evaluated 
(Table 1). Tumor tissues were histologically classified 
according to the Lauren’s classification. The study 
was conducted according to the Helsinki Declaration, 
approved by the Institutional Ethical Standards 
Committee of Peking University and informed 
consents were obtained from all patients in this study. 
RNA extraction 
Total RNA was isolated from the cells using the 
Trizol reagent (LifeTachnologies) following the 
manufacturer’s instructions. Total RNA from excised 
tissue samples was isolated using the RNeasy Mini 
Kit (Qiagen) following the manufacturer's 
recommendations. The quality and quantity of the 
extracted total RNA was assessed by the 
spectrophotometric ultraviolet (UV) instrument. 
 
Table 1. Clinical and pathologic parameters of the 70 patient 
samples used in mutation analysis. 
Tissues parameters Number 
Tumor 70 
Gender  
 Male 36 
 Female 34 
Age (years)  
 Male 31-71 
 Female 29-73 
Pathology  
 Intestinal 48 
 Diffuse 15 
 Mixed 3 
 Adenosquamous 4 
Tumor location  
 GOJ a 
 
31 
Fundus 6 
 Greater curve-body 10 
 Lesser curve-body 8 
 Body nonspecified 7 
 Antrum 8 
 Differentiation  
 Well 14 
 Moderate to poor 33 
 Poor 23 
Depth of invasion  
 Mucosa 6 
 Submucosa 7 
 Muscularis propria 10 
 Serosa/full thickness 47 
Intraperitoneal metastasis 
 
 
+ 26 
 - 44 
a Gastro-oesophageal junction. 
 
cDNA expression array analysis 
Microarray gene expression analysis was 
conducted using the nonradioactive signal 
transduction pathway finder GEArray Q series kit 
(GEArray Q Series HS-008-12/ HS-008N-12; 
SuperArray Inc., Bethesda, MD, USA), in accordance 
with the manufacturer’s instructions. This array 
membrane is comprised of 96 signal transduction 
pathway genes, a plasmid pUC18 negative control, 
and four housekeeping genes, including 
glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), cyclophilin A, ribosomal protein L13a, and 
β-actin, each of which was printed with the Tetra 
Spots format. cDNA probes were synthesized from 5 
μg of total RNA by gene-specific primers (supplied 
with the SuperArray kit) with biotin-16-dUTP. After 2 
hours of pre-hybridization at 60°C, with GEAhyb 
Hybridization Solution (SuperArray) containing 100 
μg of DNA/ml of denatured salmon sperm DNA 
(Invitrogen), the array membranes were hybridized 
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overnight with denatured cDNA probes at 60°C. The 
membranes were then washed twice with 2x SSC, 1% 
SDS, and twice with 0.1x SSC, 0.5% SDS, for 15 
minutes each at 60°C and the membrane was blocked 
for 40 minutes with GEAblocking Solution Q 
(SuperArray), then incubated with alkaline 
phosphatase-conjugated streptavidin for 10 minutes 
at room temperature. Chemiluminescent detection 
was conducted using the CDP-Star chemiluminescent 
substrate, and images of the arrays were acquired on 
X-ray films. The images were then scanned with a 
TouchToss SIS-3800 scanner (Samsung, Seoul, Korea). 
The resultant scanned images were converted to raw 
data files using the Scanalyse software. GEArray 
Analyzer software (SuperArray Inc.) was used for 
data analysis. The relative expression levels of the 
different genes were estimated via comparisons of 
their respective signal intensities with that of the 
internal controls. Genes were considered as not being 
expressed if their expression level was <20% of the 
control gene. The fold change of at least 1.5 fold is 
considered significant. The expression data was 
confirmed using the real-time PCR.  
Semi-quantitative RT-PCR and real time PCR 
assays 
First-strand cDNA was synthesized using the RT 
kit (SuperScript preamplification system; Life 
Technologies, Inc.-BRL). PR gene has two isoforms, A 
(PRA) and B (PRB) using two distinct promotors and 
translation start sites in the first exon. The two 
isoforms are indistinguishable by PCR primers we 
used for mRNA expression analysis. Primer 
sequences are available upon request. Total RNA (5 
μg) was reverse-transcribed in the presence of 25 
ng/μl of oligo (deoxythymidine) primer (Life 
Technologies, Inc.) Subsequently, 5 μl of the resulting 
cDNA were used as templates for PCR. The products 
were resolved on a 2.5% agarose ethidium bromide 
gel. Images were captured with Polaroid film under 
ultraviolet light. Products were quantified using the 
PhosphorImager and ImageQuant software 
(Molecular Dynamics, Inc.). Real-time PCR assays 
were carried out on a Bio-Rad iCycler iQ system 
(Bio-Rad, Hercules, CA, USA) using SYBR Green 
reagent [13]. 
Tissue microarray construction, 
immunohistochemical staining and evaluation 
Tissue microarrays were constructed as 
described previously [15]. Briefly, the GC tissues and 
matched normal gastric mucosa were ethanol fixed, 
paraffin embedded for creating tissue microarrays. 
H&E-stained sections were used for histological 
verification. An affinity purified goat polyclonal 
antibody POLB (sc-5927, Santa Cruz) was used for 
immunohistochemical staining. All the slides were 
stained by the avidin-biotin-peroxidase (ABC) 
protocol. The labeling index (LI) of POLB gene was 
determined by counting tumor and normal cells 
stained with the antibody. For evaluation, the total 
fields were counted microscopically under high 
power (×200). The results of POLB expression were 
graded as: negative (-), <5% of cell stained; positive 
(+), >5% of cells stained. 
Construction of eukaryotic expression vector 
and transfection  
The entire coding region of cDNA containing 
wild type POLB was amplified by RT-PCR, and the 
T889C mutant POLB was obtained by site-directed 
mutagenesis before they were cloned into pcDNA3.1 
vector. The pCMV6-XL4/PR containing PRA and PRB 
cDNA sequence was purchased from Origene 
Company. AGS cells were transfected with either 
POLB wild type or T889C mutant plasmids, along 
with PR expression plasmid. 5 X 105 cells were plated 
in 10 cm2 culture dishes, and 2.5 μg of plasmid 
DNA/dish was transfected using the calcium 
phosphate precipitation method.  
Immunofluorescence assays 
Cells were seeded at 2 × 104 cells per well on 
glass coverslips in six-well plates and fixed in 2% 
paraformaldehyde as described previously [16] . 
Confocal images were obtained using a LSM 510 
Confocal microscope (Carl Zeiss). The number of 
nuclei containing at least one localized area of 
immunofluorescence was determined by examination 
of the confocal images. Antibodies for 
immunofluorescence were as follows: goat polyclonal 
antibody POLB (sc-5927, Santa Cruz) at final 
concentration (1:600), Rabbit anti-progesterone 
receptor Polyclonal antibody (NBP1-61401, Novus 
Biologicals, 1:500), Alexa Flour 568 goat anti-mouse 
IgG (Invitrogen), 1:500 and Alexa Flour 568 goat 
anti-mouse IgG (Invitrogen), 1:500. 
Western blot analysis 
Protein extraction and Western blot analysis 
with chemiluminescent detection were as described 
[16]. The following antibodies and dilution factors 
were used: affinity purified goat polyclonal antibody 
POLB (sc-5927, Santa Cruz, 1:800), Rabbit 
anti-progesterone receptor polyclonal antibody 
(NBP1-61401, Novus Biologicals, 1:500), rabbit 
anti-actin (H-196, Santa Cruz, 1:1000), donkey 
anti-goat IgG-HRP (sc-2020, Santa Cruz, 1:2000) and 
goat anti-rabbit IgG-HRP (sc-2030, Santa Cruz, 
1:2000). 
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Transwell matrigel invasion assay 
Matrigel invasion assays were performed using 
the BD BioCoat™ Matrigel™ Invasion Chamber (BD 
Biosciences). BD BioCoat Matrigel Invasion Chambers 
provide cells with the conditions that allow 
assessment of their invasive property in vitro. It 
consists of a BD Falcon™ TC Companion Plate with 
Falcon Cell Culture Inserts containing an 8 micron 
pore size PET membrane with a thin layer of matrigel 
basement membrane matrix. Briefly, prior to the start 
of each experiment, 500 μl of warm (37°C) serum-free 
DMEM medium was added to the upper and lower 
chambers and allowed to rehydrate for 2h in a 37°C 
cell culture incubator. After 2h rehydration, the 
medium was removed from the upper and lower 
chambers, 750 μl of DMEM with 10% fetal bovine 
serum was added to lower chambers. Then 2.5 x 105 
AGS cells transfected with PR, wild-type or mutant 
POLB and negative control for 24h were seeded onto 
the top chamber cultured in 500 μl serum-free DMEM 
with 0.1% BSA in the top chamber. Cells were 
incubated in a matrigel chamber in a 37°C humidified 
incubator with 5% CO2 for 24 h. The non-invasive 
cells were removed from the upper surface of the 
membrane by scrubbing with a cotton swab and the 
invasive cells present on the bottom of the membrane 
were fixed, stained with the Diff-Quick staining 
solution and counted (five microscope fields under 
the 10X len). Experiments were done in duplicates for 
each cell line at least four times. Cell counts were 
performed on five nonoverlapping random fields for 
each chamber and four chambers were counted for 
each experimental point, and the number of invasive 
cells was compared to the corresponding control [17]. 
Statistical analysis 
Means ± SD were calculated, and statistical 
analysis was performed using one-way ANOVA, 
followed by the nonparametric Kruskal-Wallis test; P 
< 0.05 was considered statistically significant. 
Results 
POLB T889C mutation altered gene 
expression profile in GC 
In order to characterize the signal transduction 
pathways that might be modulated by the T889C 
mutation in POLB gene, we conducted a series of 
microarrays. The GEArray Signal Transduction 
Pathway Finder Gene Array membrane contains 96 
marker genes, which are associated with 18 different 
signal transduction pathways (Mitogenic Pathway, 
Wnt Pathway, Hedgehog Pathway, TGF-β Pathway, 
Survival Pathway, p53 Pathway, Stress Pathway, 
NF-κB Pathway, NFAT Pathway, CREB Pathway, 
Jak-Stat Pathway, Estrogen Pathway, Androgen 
Pathway, Calcium and Protein Kinase C Pathway, 
Phospholipase C Pathway, Insulin Pathway, LDL 
Pathway, and Retinoic Acid Pathway) and four 
housekeeping genes, including GAPDH, cyclophilin 
A, ribosomal protein L13a, and β-actin. Patient 
cohorts included paired GC and their adjacent normal 
samples from 10 patients with wild-type and 10 
patients with T889C mutant POLB gene. The 
expression profiles of GC samples with wild-type and 
T889C mutant POLB gene were analyzed by the 
Superarray platform. These data were evaluated 
using the GEArray Analyzer. Upregulated PR 
expression was detected in 8 of 10 tumor samples 
with mutant T889C POLB, while only in 3 of 10 
wild-type tumor samples compared with matched 
normal tissues (P < 0.05). In addition, upregulated 
CIAP2 (Homo sapiens baculoviral IAP 
repeat-containing 2) and Krox-24/EGR-1 (Early 
growth response 1) expression was found in 7 of 10 
tumor samples with T889C mutation, while in 3 of 10 
for CIAP2 and 4 of 10 for EGR-1 in wild-type tumor 
samples, compared with matched normal tissues. 
Upregulated c-Fos gene was identified in 6 of 10 
tumor samples with T889C mutation while only in 2 
of 10 wild-type tumor samples compared with 
matched normal tissues (P < 0.05) (Figure 1A, 1B and 
Supplementary Table 1). Since upregulated PR 
expression was frequently associated with T889C 
mutation, we determined to focus on the clinical 
significance of this association in GC prognosis. 
POLB and PR co-expression was expressed 
more frequently in GC tissue with POLB 
T889C mutation compared to that without 
the mutation 
To confirm the cDNA array results, 70 GC 
samples (Table 1) including 18 GC tissues with the 
mutation and 52 without were subjected to real-time 
PCR analysis. POLB overexpression was detected in 
16 of 18 (88.9%) GC tissues with T889C mutation, and 
31 of 52 (59.6 %) GC tissues without the mutation. PR 
overexpression was observed in 13 of 18 (72.2%) GCs 
with the mutation whereas in 14 of 52 (26.9 %) GCs 
without the mutation.  
There was a significant positive correlation 
between T889C point mutation and PR 
overexpression (P < 0.05). Co-expression of POLB and 
PR was observed in 13 of 18 (72.2%) GCs with the 
mutation (including 11 co-overexpression and 2 
co-downexpression) whereas in 9 of 52 (17.3%) GCs 
without the mutation (Figure 1C and 1D). 
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Figure 1. Co-expression of POLB and PR associated with T889C mutation. A. Superarray Q Series HS-008-12/ HS-008N-12. B. A representative cDNA 
array results to determine T889C mutation related genes in human GC tissues with and without T889C mutation. Gene expression was compared with matched 
normal adjacent tissues. Detectable upregulated genes upon normalization were marked in arrows. C. A representative gel-based RT-PCR for POLB and PR mRNA 
expression in tumor and the matched normal tissue from representative GCs. D. Real-time PCR detection of 11 co-overexpression and 2 co-downexpression of 
POLB and PR mRNA in GCs with the mutation in tumor (T) vs. matching normal (N). 
 
To examine the expression in protein level, we 
constructed tissue microarrays consisting of GC 
samples from the 70 patients (Table 1) and 20 normal 
adjacent tissues (5 matched adjacent normal tissues 
with the T889C mutation and 15 matched adjacent 
normal tissues without the mutation). Expression of 
POLB and PR status was analyzed by 
immunohistochemistry. The positive hybridization 
signals of POLB protein were observed in 47 (67.1%) 
of 70 GCs, including 16 of 18 (88.9%) GC tissues with 
T889C mutation, of which one was from the 5 
matched samples, and 31 of 52 (59.6 %) GC tissues 
without the mutation, of which four were from the 15 
matched samples (Table 2). Positive PR proteins were 
detected in 30 of 70 (42.9%) GCs, including 13 of 18 
(72.2%) GC tissues with T889C mutation and 17 (32.7 
%) of 52 GC tissues without the mutation. 
Co-expression of POLB and PR protein was detected 
in 10 of 18 (55.6%) GCs with the mutation, including 9 
co-positive signals (POLB+/PR+) and one co-negative 
signal (POLB-/PR-). Co-expression of two proteins 
was detected in 7 of 52 (13.5%) GCs without the 
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mutation, including 4 POLB+/PR+ and 3 POLB-/PR-, 
in addition to 3 of 20 (15%) matched adjacent normal 
tissues (Figure 2 and Table 2). The co-expression of 
two proteins was significantly different between GCs 
with- and without- the T889C mutation (p<0.01). Our 
data suggests that T889C mutation significantly 
correlated with the co-expression of POLB and PR 
genes. 
Co-expression of POLB and PR genes is 
associated with intraperitoneal metastasis 
(IM) 
We next investigated whether the co-expression 
of POLB and PR correlates with clinicopathological 
parameters, such as gender, age, tumor location, 
depth of invasion, differentiation and metastasis in 
the 70 samples from primary GC patients. Of the 70 
samples from GC patients, IM are present in 26 
(37.1%) of the patients (Table 1). In 17 patients with 
T889C mutation, IM was presents in 7 of 9 (77.8%) 
with POLB+/PR+ signals, and in 3 of 8 (37.5%) with 
POLB+/ PR- or POLB-/ PR+ signals. In 49 patients 
with wild type POLB, IM was present in 2 of 4 (50%) 
with POLB+/PR+ signals, 14 of 45 (31.1%) patients 
with non- coexpression signals. There were significant 
differences between the patients with coexpression 
and non-coexpression of POLB and PR signals in 
regard to IM (p = 0.002, Table 3) in patients with 
T889C mutation. Thus, co-expression of POLB and PR 
was more likely associated with increased 
susceptibility of IM in patients with T889C mutation. 
Our results suggest that co-expression of POLB and 
PR plays a role during metastasis of GC with T889C 
mutation. 
 
Table 2. Correlation of POLB and PR expression between GC 
samples with mutant T889C and wild type POLB on tissue arrays. 
Samples POLB PR Co-expression Total 
 + － + － Co+* Co－* +/－   
Tumor      
 Mutation  16(88.9%) 2 13 (72.2%) 5 9(50%) 1 8 18 
Wild type 31(59.6%) 21 17(26.9%) 35 4(7.7%) 3 45 52 
Total 47 23 30 40 13 4 53 70 
Normal     
Mutation 
matched 
1(25%) 4 1(20%) 4 1(20%) 0 4 5 
Wild type 
matched 
4(36.3%) 11 1(6.7%) 14 1(6.7%) 1 13 15 
Total 5 15 2 18 2 1 17 20 
*p < 0.01. 
 
 
Figure 2. Coexpression of PR and POLB protein in representative GC tissues with T889C mutation. Panels A and B show protein signals stained with 
PR and POLB antibodies in same GC sample, so do panels C and D for another GC case. Panels E and F show protein signals stained with PR and POLB antibodies 
in the same matched normal sample. 
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Table 3. Coexpression of POLB and PR associated with increased 
IM. 
Protein signals POLB+/ PR+ POLB-/PR- POLB+/PR- and 
POLB-/PR+ 
Total 
POLB 
Mutation  
9  1 8 18 
IM 7 (77.8%)* 0 3 (37.5%) 10 
No IM 2 (22.2%)* 1 5 (62.5%) 8 
POLB Wild 
type 
4 3 45 52 
IM 2 (50%) 0 14 (31.1%) 16 
No IM 2 (50%) 3 31 (68.9%) 36 
*p < 0.01. 
 
Transfected T889C mutation elevates PR 
expression in human GC cell lines 
Having established the relationship between 
T889C mutant POLB and PR gene expression in GC 
tissues, we tested whether the T889C mutant POLB 
affects PR levels in vitro. We analyzed PR expression 
on mRNA level by real time PCR and protein level by 
Western blot and Immunofluorescence after 
transfecting plasmids containing T889C mutant POLB 
or wild type POLB into AGS cells. PR expression was 
significantly increased in T889C mutant POLB 
transfected cell lines compared to the cells expressing 
wild-type POLB (Figure 3A, 3C and 3E). There was no 
significant change of POLB expression when 
transfected pCMV6-XL4/PRB PR expression plasmid 
to AGS cells (Figure 3B, 3D and 3E). These results 
indicate that the T889C mutant POLB have somehow 
increased PR expression, though the exact mechanism 
that is yet to be elucidated.  
Co-transfection of T889C mutant POLB and 
PR promotes cell invasion in human GC cell 
lines 
We have observed the relationship between 
co-expression of POLB and PR, and increased IM. 
Since cell migration is a critical property for cancer 
cell metastasis, we further investigated the cell 
invasiveness using in vitro invasion assays. Cells 
co-transfected with T889C mutant POLB and PR 
showed a significant increase in the number of 
migrated cells, compared to those co-transfected with 
wild type POLB and PR, or T889C mutant POLB, or 
wild type POLB or PR alone (Figure 3F). We found 
that AGS cell line transfected with mutant POLB 
plasmid exhibited significant increase of invasion 
ability compared to the wild-type POLB as well as the 
empty vector control (p<0.01) (Figure 3G). Moreover, 
AGS cell line transfected with mutant POLB plasmid 
along with PR expression plasmid showed more 
significant invasion compared to the wild-type POLB 
plasmid with PR expression plasmid (p<0.01) (Figure 
3G). These results indicate that T889C mutation alone, 
or with enhanced PR expression promotes invasion 
properties of GC cells. 
Discussion 
Based on our previous studies [14, 18], we 
predicted that the T889C mutation in POLB gene 
mediates GC progression by affecting the global gene 
expression and associated molecular pathways. Thus, 
our goal was to identify the differentially expressed 
genes and understand the mechanisms of their 
differential regulation by comparing wild type and 
T889C mutant POLB gene in GC tissue and cell line. In 
this study, we performed targeted gene expression 
profiling to understand how the T889C mutation in 
POLB gene altered molecular pathways associated 
with GC. We identified dramatic gene expression 
differences at the transcriptional level between wild 
type and mutant T889C POLB gene carrying GCs. The 
results were further verified by RT-PCR, real-time 
PCR and immunofluorescence assays. Interestingly, 
we identified a T889C mutation-driven gene signature 
that is associated with significant PR overexpression 
in human GCs, resulting in increased IM. However, 
we did not observe a correlation between 
overexpression of PR and POLB with either age or sex 
[18]. Additionally, transfection of GC cells expressing 
only mutant T889C POLB increased PR expression, 
which further implicated that the T889C mutation 
upregulated PR expression. Our studies support a 
mechanistic link between mutant T889C POLB in PR 
specific action and GC cell metastasis.  
Existing data suggest that sex hormonal factors 
are involved in a variety of cancers including gastric 
cancer [19]. Progesterone has been found to increase 
the migration of breast cancer cells [20]. The role of 
sex hormones in the pathogenesis of cancer is still not 
clear. Our data suggest that the increased IM in GC 
associated with mutant T889C POLB may be due to 
the modulation of PR overexpression, which is related 
to tumor metastatic pathways. Further studies may 
shed light on the exact mechanisms of these important 
findings. 
Conclusions 
The T889C point mutation in POLB gene is 
strongly associated with increased PR expression in 
both GC tissue and cell line. The T889C 
mutation-associated PR overexpression increased IM 
in GC. Therefore, detection of T889C 
mutation-associated PR overexpression may serve as 
a biomarker for an adverse prognosis of human GC. 
The exact mechanism of how POLB mutation affects 
PR expression is yet to be elucidated.  
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Figure 3. The T889C mutant POLB increase PR expression in human GC cell line, AGS. Cells were transfected with pcDNA3.1, wild type POLB, T889C 
mutant POLB, PR plasmids and co-transfection of these plasmids into AGS cell line. The expression of PR and POLB was analyzed by real time PCR (A and B), 
Western blot (C and D) and immunofluorescence (E, red signals are PR, and green signals are POLB). F. The effect on cell invasion by co-transfection of T889C 
mutant expression vector and PR expression plasmid in human GC cell line, AGS. The Transwell assay with matrigel was performed for the invasion activity of AGS 
cells transfected with pcDNA3.1, WT POLB, T889C mutant POLB, PR plasmids and co-transfection of these plasmids. Cells co-transfected T889C mutant POLB with 
PR show a significant increase in the number of migrated cells. Co-transfected wild type POLB and PR show a slightly weak migration, while single transfection of WT 
POLB, T889C mutant POLB, and PR presents a decreased migration. G. Invasion ability of the cells is displayed as an absolute cell numbers. Results are displayed as 
mean data ± SE. (**P <0.01). Five fields of unit area on each membrane or whole membrane were counted for cell numbers, and the experiments were repeated at 
least four times in duplicate. 
 
Supplementary Material  
Supplementary table 1.  
http://www.jcancer.org/v07p1472s1.xlsx  
Abbreviations 
GC, Gastric cancer; POLB, DNA polymerase 
beta; PR, progesterone receptors; IM, intraperitoneal 
metastasis. 
Acknowledgements 
We would like to thank individual patients for 
participating in this study. This work was supported 
by grants from the National Key Basic Research 
Program Project of China (Grant# 2004CB518708), the 
National Natural Science Foundation of China (NSFC) 
(Grant# 39625016), and the National Bio-Tech 863 
 Journal of Cancer 2016, Vol. 7 
 
http://www.jcancer.org 
1480 
Program (Grant# 2012-AA02A203) to YL, and the 
Elaine H. Snyder Cancer Research Award to SWF. 
Authors’ contributions 
XT contributed to conception and design, 
development of methodology, acquisition of data, 
analysis and interpretation of data, statistical 
analyses, writing of the manuscript. XW performed 
microarray data analysis and interpretation, and 
edited the manuscript. SR performed qRT-PCR and 
matrigel invasion assays and helped write/revise the 
manuscript. HY was involved in patient’s accrual and 
performed surgery. ZL identified pathological cases 
with clinical information. WA performed array data 
analysis. WL and JC involved in cell culture and 
matrigel invasion assays. GL designed and 
interpreted data and helped write the manuscript. 
RSS and SWF analyzed data, and revised the 
manuscript. YL designed and interpreted data, and 
wrote and revised the manuscript. All authors read 
and approved the final version of this manuscript. 
Competing interest 
The authors declare that they have no competing 
interests. 
References 
1. Al-Marzoqee FY, Khoder G, Al-Awadhi H, John R, Beg A, Vincze A, et al. 
Upregulation and inhibition of the nuclear translocation of Oct4 during 
multistep gastric carcinogenesis. Int J Oncol. 2012; 41: 1733-43. 
doi:10.3892/ijo.2012.1608. 
2. Tokunaga A NK, Matsukura N, Tanaka N, Onda M, Shirota A, Asano G, 
Hayashi K. Estrogen and progesterone receptors in gastric cancer. Cancer. 
1986; 57: 1376-9. 
3. Brambilla G MA. Are some progestins genotoxic liver carcinogens. Mutat Res. 
2002; 12: 155-63. 
4. Oshima CT WD, Catarino RM, Mattos D, Forones NM. Estrogen and 
progesterone receptors in gastric and colorectal cancer. 
Hepatogastroenterology. 1999; 46: 3155-8. 
5. Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, et al. 
Phosphorylated and sumoylation-deficient progesterone receptors drive 
proliferative gene signatures during breast cancer progression. Breast cancer 
research : BCR. 2012; 14: R95. doi:10.1186/bcr3211. 
6. Masaoka A, Horton JK, Beard WA, Wilson SH. DNA polymerase beta and 
PARP activities in base excision repair in living cells. DNA Repair (Amst). 
2009; 8: 1290-9. doi:10.1016/j.dnarep.2009.08.004. 
7. Cağlayan M BV, Sassa A, Prasad R, Wilson SH. Role of polymerase β in 
complementing aprataxin deficiency during abasic-site base excision repair. 
Nat Struct Mol Biol. 2014 21: 497-9. 
8. Prasad R WJ, Hou EW, Wilson SH. Pol β associated complex and base excision 
repair factors in mouse fibroblasts. Nucleic Acids Res. 2012; 40: 11571-82. 
9. Mark WY, Liao JC, Lu Y, Ayed A, Laister R, Szymczyna B, et al. 
Characterization of segments from the central region of BRCA1: an 
intrinsically disordered scaffold for multiple protein-protein and 
protein-DNA interactions? J Mol Biol. 2005; 345: 275-87. 
doi:10.1016/j.jmb.2004.10.045. 
10. Starcevic D, Dalal S, Sweasy JB. Is there a link between DNA polymerase beta 
and cancer? Cell Cycle. 2004; 3: 998-1001. doi:1062 [pii]. 
11. Khanra K, Panda K, Bhattacharya C, Mitra AK, Sarkar R, Banerjee S, et al. 
Association between newly identified variant form of DNA polymerase 
beta(Delta 208-304) and ovarian cancer. Cancer Biomark. 2012; 11: 155-60. 
doi:Doi 10.3233/Cbm-2012-0275. 
12. Sweasy JB LT, Starcevic D, Sun KW, Lai CC, Dimaio D, Dalal S. Expression of 
DNA polymerase β cancer-associated variants in mouse cells results in cellular 
transformation. Proc Natl Acad Sci U S A. 2005; 102: 14350-5. 
13. Donigan KA HS, Eckert KA, Sweasy JB. The human gastric cancer-associated 
DNA polymerase β variant D160N is a mutator that induces cellular 
transformation. DNA repair. 2012; 11: 381-90. 
14. Tan XH, Zhao M, Pan KF, Dong Y, Dong B, Feng GJ, et al. Frequent mutation 
related with overexpression of DNA polymerase beta in primary tumors and 
precancerous lesions of human stomach. Cancer letters. 2005; 220: 101-14. 
doi:10.1016/j.canlet.2004.07.049. 
15. Yang YH, Deng H, Li WM, Zhang QY, Hu XT, Xiao B, et al. Identification of 
matrix metalloproteinase 11 as a predictive tumor marker in serum based on 
gene expression profiling. Clin Cancer Res. 2008; 14: 74-81. doi:Doi 
10.1158/1078-0432.Ccr-07-1179. 
16. Tan X, Anzick SL, Khan SG, Ueda T, Stone G, Digiovanna JJ, et al. Chimeric 
negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated 
with melanoma, deafness, and DNA repair deficiency. Hum Mutat. 2013; 34: 
1250-9. doi:10.1002/humu.22354. 
17. Tan X, Peng J, Fu Y, An S, Rezaei K, Tabbara S, et al. miR-638 mediated 
regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in 
triple negative breast cancer. Breast cancer research : BCR. 2014; 16: 435. 
doi:10.1186/s13058-014-0435-5. 
18. Tan X, Wang H, Luo G, Ren S, Li W, Cui J, et al. Clinical significance of a point 
mutation in DNA polymerase beta (POLB) gene in gastric cancer. Int J Biol Sci. 
2015; 11: 144-55. doi:10.7150/ijbs.10692. 
19. Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex 
hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. 
Cancer epidemiology, biomarkers & prevention : a publication of the 
American Association for Cancer Research, cosponsored by the American 
Society of Preventive Oncology. 2012; 21: 20-38. 
doi:10.1158/1055-9965.EPI-11-0834. 
20. Diaz J, Aranda E, Henriquez S, Quezada M, Espinoza E, Bravo ML, et al. 
Progesterone promotes focal adhesion formation and migration in breast 
cancer cells through induction of protease-activated receptor-1. J Endocrinol. 
2012; 214: 165-75. doi:Doi 10.1530/Joe-11-0310. 
